|
gptkbp:instanceOf
|
Cannabis
|
|
gptkbp:bindingTarget
|
gptkb:CB1_receptor
gptkb:CB2_receptor
|
|
gptkbp:boilingPoint
|
175–178 °C (at 0.05 mmHg)
|
|
gptkbp:CASNumber
|
5957-75-5
|
|
gptkbp:category
|
gptkb:chemical_compound
recreational drug
phytocannabinoid
|
|
gptkbp:chemicalFormula
|
C21H30O2
|
|
gptkbp:color
|
colorless to pale amber
|
|
gptkbp:controlledSubstanceSchedule
|
gptkb:Canada
gptkb:United_Kingdom
United States (some states)
|
|
gptkbp:effect
|
relaxation
euphoria
altered perception
|
|
gptkbp:eliminationHalfLife
|
unknown
|
|
gptkbp:firstIsolatedFrom
|
gptkb:Raphael_Mechoulam
1965
|
|
gptkbp:foundIn
|
Cannabis
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
Δ8-THC
|
|
gptkbp:isomerOf
|
gptkb:Δ9-THC
|
|
gptkbp:IUPACName
|
gptkb:(6aR,10aR)-6,6,9-trimethyl-3-pentyl-6a,7,8,10a-tetrahydro-6H-benzo[c]chromen-1-ol
|
|
gptkbp:legalStatus
|
varies by country
|
|
gptkbp:meltingPoint
|
63–66 °C
|
|
gptkbp:metabolism
|
liver
|
|
gptkbp:molecularWeight
|
314.464 g/mol
|
|
gptkbp:otherName
|
gptkb:Δ8-THC
gptkb:Delta-8-tetrahydrocannabinol
gptkb:Delta-8-THC
|
|
gptkbp:producedBy
|
degradation of Δ9-THC
|
|
gptkbp:psychoactive
|
true
|
|
gptkbp:PubChem_CID
|
2977
2869
|
|
gptkbp:relatedTo
|
gptkb:THCV
gptkb:CBD
gptkb:CBN
|
|
gptkbp:routeOfAdministration
|
oral
inhalation
sublingual
|
|
gptkbp:smiles
|
CCCCC1=CC2=C(C=C1)OC3(C(C2)C(C)(C)C3)O
|
|
gptkbp:solubility
|
insoluble in water
soluble in organic solvents
|
|
gptkbp:toxicity
|
low
|
|
gptkbp:UNII
|
KHE74118FM
|
|
gptkbp:usedFor
|
recreational purposes
potential medical uses
|
|
gptkbp:bfsParent
|
gptkb:THC
|
|
gptkbp:bfsLayer
|
6
|